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Abstract 
Introduction:  Retinoic acid (RA) signaling is a well known regulator of 
trophoblast differentiation and placental development, and maternal decidual 
cells are recognized as the source of much of this RA. We explored possible 
trophoblast-derived sources of RA by examining the expression of RA 
synthesis enzymes in the developing mouse placenta, as well as addressed 
potential sites of RA action by examining the ontogeny of gene expression for 
other RA metabolizing and receptor genes. Furthermore, we investigated the 
effects of endogenous RA production on trophoblast differentiation.    
Methods:  Placental tissues were examined by in situ hybridization and 
assayed for RARE-LacZ transgene activity to locate sites of RAR signalling.  
Trophoblast stem cell cultures were differentiated in the presence of ALDH1 
inhibitors (DEAB and citral), and expression of labyrinth (Syna, Ctsq) and 
junctional zone (Tpbpa, Prl7b1, Prl7a2) marker genes were analysed by qRT-
PCR.  
Results:  We show Aldh1a3 is strongly expressed in a subset of ectoplacental 
cone cells and in glycogen trophoblast cells of the definitive murine placenta. 
Most trophoblast subtypes of the placenta express RA receptor combinations 
that would enable them to respond to RA signaling. Furthermore, expression 
of junctional zone markers decrease in differentiating trophoblast cultures 
when endogenous ALDH1 enzymes are inhibited. 
Discussion: Aldh1a3 is a novel marker for glycogen trophoblast cells and their 
precursors and may play a role in the differentiation of junctional zone cell 
types via production of a local source of RA.   
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1. Introduction 1 
In mice, the process of placentation requires the expansion of a 2 
trophectoderm-derived stem cell population into specialized trophoblast cells 3 
with unique behaviours.  Early in development an intermediary pool of 4 
progenitors, the ectoplacental cone (EPC), give rise to cells of the definitive 5 
junctional zone (JZ) comprising glycogen trophoblast (GlyT) and 6 
spongiotrophoblast (SpT) cells plus additional subtypes of trophoblast giant 7 
cells (TGCs) (1,2). GlyT and SpT cells of the JZ form the intermediate layer of 8 
the definitive placenta and are thought to play endocrine and structural roles, 9 
whereas TGCs, which differ in subtype depending on their vascular location, 10 
manipulate and direct maternal blood supply while likewise contributing to 11 
placental hormone function (1-3).  In contrast, cells of the chorion give rise to 12 
trophoblast subtypes of the labyrinth zone, the inner layer of the placenta 13 
involved in mediating fetal-maternal exchange.  14 
RA signaling is known to regulate key aspects of placental development and 15 
function. Mice deficient in retinoid X receptors (RXRα or β) or peroxisome 16 
proliferator activated receptors (PPARβ/δ or γ) have severe placental 17 
phenotypes (4-7).  Additionally, deficiencies in maternal vitamin A result in 18 
placental failure in rodents (8,9), and in vitro studies have shown the 19 
involvement of retinoids in the upregulation of pregnancy specific hormones 20 
produced by trophoblast cells (10,11) and the regulation of trophoblast 21 
differentiation (12,13) and invasion (14,15). 22 
Aldehyde dehydrogenase family 1, member A3 (ALDH1A3) belongs to a large 23 
gene family of enzymes known to metabolise a wide variety of aldehydes 24 
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(15,16). ALDH1A3 specifically oxidizes retinal to retinoic acid (RA) and is 25 
differentially expressed in developing embryonic tissues and adult organs (15-26 
17). The RA produced by ALDH1A3 in rodents contributes to the development 27 
of skin and hair follicles, brain, tooth buds, lungs, olfactory bulbs, kidneys, 28 
eyes, skeletal muscle and seminal vesicles (17-19).  29 
The source of RA acting on trophoblast cells during placentation is thought to 30 
be primarily from maternal decidual cells (13,20). In the present study, we 31 
report that a subset of cells within the EPC and later, GlyT cells of the 32 
definitive murine placenta, express Aldh1a3.  This suggests that GlyT are a 33 
local source of RA during placental development. Furthermore, we explored 34 
what possible role trophoblast-derived RA may be playing in the placenta by 35 
analyzing the expression patterns of retinoic acid metabolizing enzymes and 36 
receptors in the developing placenta, as well as by differentiating trophoblast 37 
stem cells in the absence of endogenous RA production.  38 
 39 
2. Methods 40 
2.1 Animals and tissue preparation 41 
 42 
C57BL6 mice were used for all in situ hybridisation (ISH) and Best’s Carmine 43 
staining procedures.  Recognition of a seminal plug was designated 44 
embryonic day (E) 0.5.  Whole implantation sites (E8.5-E10.5) or placentas 45 
(E12.5-E18.5) were dissected in cold phosphate buffered saline (PBS), fixed 46 
overnight in 4% paraformaldehyde (PFA) at 4˚C and processed for paraffin 47 
embedding.    48 
 49 
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RARE-LacZ homozygous transgenic male mice maintained on a CD1 50 
background (kindly provided by Peter Koopman, IMB) were crossed with wild 51 
type CD1 females for detection of retinoic acid response element (RARE) 52 
activity. Samples were fixed in 2% PFA/0.2% glutaraldehyde solution in 1 x 53 
PBS for 4 hours at 4˚C before freezing in OCT-media (Tissue Tek), as 54 
previously described (1). Animals were housed in accordance with the 55 
University of Queensland animal facility guidelines, and the University of 56 
Queensland Animal Ethics Committee approved all experiments.   57 
 58 
2.2 Histology 59 
 60 
β-galactosidase detection was performed on 10 µm OCT sections as 61 
previously described (1).  Seven µm paraffin sections were used for Best’s 62 
Carmine staining as previously described (21). 63 
 64 
2.3 In Situ Hybridisation 65 
 66 
Genes targeted for in situ hybridization (ISH) analysis are listed in 67 
Supplemental Table 1.  cDNA probe templates were isolated by gel extraction 68 
(Qiagen Minelute Gel Extraction Kit) or via “PCR clean up” (Qiagen Minelute 69 
PCR purification) and sequence verified by the Australian Genome Research 70 
Facility (AGRF).  Digoxigenin (DIG) labeled cRNA probes were synthesized in 71 
accordance with manufacturer’s directions (Roche) and as previously 72 
described (22).  In situ hybridizations on 7µm paraffin-embedded sections 73 
were done as previously described (23).  Negative controls included the use 74 
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of sense probes for all mRNA analyzed, and positive controls included the 75 
detection of antisense probes in positive control tissues. 76 
 77 
2.4 Trophoblast stem cell culture 78 
 79 
Trophoblast stem (TS) cells were cultured as previously described (24). 80 
Differentiation of TS cells was achieved by replacing conditioned media with 81 
TS media alone (without FGF4 or heparin) in the presence of either citral 82 
(30µM), diethylaminobenzaldehyde (DEAB; 100µM) or DMSO (vehicle 83 
control).  84 
 85 
2.5 RNA isolation, cDNA production and qRT-PCR  86 
 87 
RNA was isolated from placental tissue and TS cell cultures using TRIzol 88 
reagent (Life Technologies) following the manufacturer’s instructions.  Total 89 
RNA (1µg) was used to generate cDNA (Qiagen Quantitect cDNA synthesis 90 
kit) according to the manufacturer’s instructions.  mRNA expression levels 91 
were assessed by quantitative real-time PCR (qRT-PCR).  Primer sequences 92 
are listed in Supplemental Table 2.  Each SYBR green qRT-PCR reaction 93 
contained 5µL SYBR green (ABI), 1µL of cDNA (150 ηg/µL) plus 4µM primers 94 
in a final volume of 10µL.  Relative cDNA levels were analyzed in triplicate for 95 
each independent experimental replicate (n=3).  Differences between 96 
expression levels were determined by the Pfaffl method of qRT-PCR analysis 97 
with normalization to Rn18s, Hprt1 and Rpl13a gene expression (25).  98 
 99 
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2.6 Statistics 100 
 101 
To determine statistically significant differences (* p<0.05; ** p<0.005) the 102 
mean relative level of expression plus standard deviations were calculated for 103 
all qRT-PCR results and unpaired, two-tailed t-tests were performed.  All 104 
graphs and statistics were performed using GraphPad Prism 5 software. 105 
 106 
3. Results 107 
3.1 Aldh1a3 expression is restricted to a subset of ectoplacental cone cells 108 
and glycogen trophoblast cells of the definitive mouse placenta. 109 
 110 
Expression of Aldh1a3 mRNA was analyzed spatially and temporarily by in 111 
situ hybridisation (ISH) in mouse implantation sites and placental sections 112 
from E8.5 to E18.5 (Fig 1 A/B, Fig S1/S2).  Midline coronal sections of 113 
implantation sites at E8.5 show Aldh1a3 expression in some decidual cells 114 
and within a subpopulation of EPC trophoblast cells (Fig 1A). Expression 115 
patterns for Pcdh12 and Aldh1a3 within the developing EPC match, while 116 
expression of Prl7b1 and Aldh1a3 do not entirely overlap (Fig S3, Fig 1G/H).  117 
By E10.5 expression of Aldh1a3 is seen within a subset of cells situated in the 118 
JZ, which by E12.5-E18.5 were also observed clustered within the maternal 119 
decidua (Fig 1B, Fig S1). Aldh1a3 positive cells were confirmed to be GlyT 120 
based on their distinct cell morphology and by comparison with serial sections 121 
stained with Best’s Carmine to detect glycogen content (Fig 1C/D), Prl7b1 122 
(Fig 1E/F) and Pcdh12 expression (Fig S3).  Expression of Aldh1a3 in uterine 123 
decidual cells was not observed from E10.5 to E18.5 (Fig 1B, Fig S1). 124 
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 125 
GlyT cells form a layer around luminal cells of the maternal blood spaces, a 126 
layer known to include SpA-TGC (lining spiral arteries) and C-TGCs (lining the 127 
central canals) (26).  Serial coronal sections comparing Aldh1a3 and Prl7b1 128 
expression at E14.5 nicely recapitulate this phenomenon (Fig 1I/J).  Aldh1a3 129 
and Prl7b1 expression marks GlyT cells in the maternal decidua, adjacent to 130 
SpA-TGCs that express Prl7b1 only (Fig 1J). Interestingly, around mid-131 
gestation GlyT cells immediately adjacent to the maternal spiral arteries 132 
appear to lose their Aldh1a3 expression (Fig 1I). 133 
 134 
3.2 Expression of retinoic acid metabolizing enzymes within the mouse 135 
placenta.  136 
 137 
Messenger RNA expression patterns for RA metabolizing enzymes Aldh1a1 138 
and Aldh1a2 plus RA catabolizing enzymes Cyp26a1, Cyp26b1 and Cyp26c1 139 
were analyzed by ISH. Aldh1a2 was expressed at the extreme mesometrial 140 
pole of the E8.5 uterus, as well as within the embryo proper, although no 141 
expression was seen in the developing EPC or chorion (Fig 2A). By E14.5, 142 
strong expression of Aldh1a2 was observed throughout the entire maternal 143 
decidual compartment of the mature placenta (Fig 2B). Cyp26b1 expression 144 
was observed in the uterus at the anti-mesometrial pole and in the P-TGC 145 
layer surrounding the conceptus at E8.5 (Fig 2C/D), while expression was 146 
detected sporadically amongst clusters of GlyT cells within the JZ by E14.5 147 
(Fig 2E).  Expression of Aldh1a1, Cyp26a1 or Cyp26c1 was not observed in 148 
the placenta at either developmental stage (Fig S4).     149 
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 150 
3.3 Placental sites of potential RA action. 151 
 152 
To determine which placental cell types may be capable of responding to 153 
GlyT-derived RA, analysis of retinoid receptor (Rara/b/g and Rxra/b/g) 154 
expression was analyzed at E8.5 and E14.5.  Non-classical RA signaling was 155 
also examined through ISH analysis of the alternate RXR binding partners the 156 
Ppar isoforms (Ppard/g).  For brevity ISH results are summarised in Figure 3 157 
(individual ISH images have been included in supplemental information; Fig 158 
S5-S12 and a detailed description in Supplemental file 1). Briefly, most 159 
placental trophoblast subtypes, along with maternal decidual cells, appear to 160 
express some combination of RA receptors.  In theory, this expression should 161 
allow these cells to respond to RA signaling.    162 
 163 
RARE-LacZ reporter mice (27) were used to assess the presence of classical 164 
RA signaling through RARs during placental development. While robust LacZ 165 
staining was observed in the developing E8.5 embryo, no expression of the 166 
LacZ transgene could be detected in the EPC or chorion (Fig 4A). Punctate 167 
LacZ expression was observed in a small subset of cells dispersed throughout 168 
the labyrinth and JZ at E14.5 (Fig 4B/C). 169 
 170 
3.4 Inhibition of endogenous ALDH activity alters trophoblast stem cell 171 
differentiation. 172 
 173 
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Citral and DEAB (acting as non-competitive and competitive ALDH1 174 
substrates, respectively) were employed to inhibit ALDH1 activity, and 175 
therefore the synthesis of endogenous RA, in the trophoblast stem (TS) cell 176 
model (28). TS cells differentiated over six days in the presence of citral, 177 
DEAB or DMSO vehicle were analysed by qRT-PCR for changes in 178 
expression of several trophoblast cell type markers.  Labyrinth cell type 179 
specific genes Syna (syncytiotrophoblast layer-I), Ctsq (S-TGCs), and P-TGC 180 
marker Prl3d1/PL1 showed no significant change in mRNA expression 181 
following the addition of either citral or DEAB.  In contrast, JZ cell type 182 
markers Tpbpa (EPC, SpT and GlyT), Prl7a2 (SpT specific) and Prl7b1 (GlyT 183 
and SpA/C-TGC specific) were expressed at significantly lower levels after six 184 
days of differentiation in the presence of citral. Similar trends were observed 185 
in the presence of DEAB, with the reduction of Tpbpa and Prl7b1 statistically 186 
significant (Fig 5, Fig S13). Aldh1a3 expression in differentiating TS cells was 187 
confirmed by qRT-PCR (Fig S14); surprisingly we also found that TS cells 188 
expressed Aldh1a2 (data not shown), which is not expressed by trophoblast 189 
but by decidual cells in vivo.  190 
 191 
Discussion 192 
 193 
ALDH1A3, along with other ALDH1 family members (ALDH1A1 and A2), 194 
generate RA (15,16).  Recently Aldh1a3 has been recognized as a marker of 195 
various stem cell populations, including cancer stem cells, and is suggested to 196 
play a role in the homeostasis of these progenitors (29-31).  In the current 197 
study we demonstrate expression of Aldh1a3 first in a subset of EPC 198 
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progenitor cells, and then within GlyTs of the definitive placenta. While gene 199 
expression patterns do not prove cell lineage, the tight restriction of Aldh1a3 200 
expression to GlyT cells of the definitive placenta strongly suggests that 201 
earlier expression within the EPC marks GlyT progenitors. GlyT were 202 
originally thought to arise from SpT of the JZ, until Bouillot et al. demonstrated 203 
Pcdh12 expression in a subset of central EPC cells at E7.5, followed by 204 
restricted expression in GlyT but not SpT cells of the JZ (32). Recent cell 205 
lineage tracing experiments support this notion; SpA-TGCs, C-TGCs and 206 
GlyT, but not SpT cells, are derived from Prdm1 positive EPC progenitors 207 
(33). We analysed Aldh1a3 and Prl7b1 expression in E8.5 serial sections. 208 
Prl7b1 expression is restricted to the Prdm1 lineage, first expressed by subset 209 
of EPC cells and then by SpA-TGCs, C-TGCs and GlyT of the definitive 210 
placenta (22). We observed cells positive for Prl7b1 but negative for Aldh1a3 211 
near the top of the EPC, consistent with the location of SpA-TGCs, as well as 212 
cells with overlapping Aldh1a3 and Prl7b1 expression within the core of the 213 
EPC, consistent with the location of future GlyT.  Interestingly, we also 214 
observed Aldh1a3+/Prl7b1- cells at the base of the EPC, suggesting Aldh1a3 215 
expression may be an earlier marker of GlyT cell progenitors than Prl7b1. 216 
Lineage tracing experiments using an Aldh1a3-driven Cre recombinase-217 
expressing transgenic mouse line would illuminate the early developmental 218 
origins of the SpA-TGC, C-TGC and GlyT lineages within the developing 219 
EPC. 220 
 221 
It has been suggested that the RA required for placentation is maternally 222 
derived (13,20).  Expression of Aldh1a3 by a subset of EPC progenitors, and 223 
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subsequently by GlyT cells of the JZ, suggests an additional source of 224 
placental RA. RA produced by EPC/GlyT cells would be positioned to 225 
influence the differentiation or maintenance of most placental cell types, but 226 
JZ subtypes in particular.  227 
 228 
Altered RA signalling has previously been shown to perturb placental 229 
development; the dearth of Rar expression in trophoblast cells, the lack of 230 
placental phenotypes in Rar mutant mice (34), and the absence of LacZ 231 
staining in RARE-LacZ placentas reiterate that non-classical RA pathways are 232 
likely responsible.  Retinoid X receptors are well placed in the developing and 233 
mature placenta to propagate 9-cis-RA signaling, and mouse knockout 234 
studies have highlighted their fundamental importance, possible redundancy, 235 
and potential for homodimerisation.  Rxra-/- and Rxra-/-/Rxrb-/- double null 236 
mutants die in mid gestation due to a number of placental defects including 237 
decreased GlyT cells, reduced JZ and disorganized labyrinth development 238 
(4,5). 239 
 240 
Ppard and Pparg null mutants similarly reveal key roles for these RXR binding 241 
partners in placentation.  Unlike RXRs, PPARs are noted for their non-242 
redundant roles in placentation. The loss of Ppard in vivo leads to smaller 243 
placentas with limited decidual contact, often resulting in placental 244 
detachment and lethality by E10.5 (7).  In line with this we note that all Rxrs 245 
and Ppard are expressed in the P-TGC layer.  Alternatively, Pparg knockout 246 
mice exhibit placental failure at E9.5 reportedly due to decreased 247 
differentiation of terminal trophoblast cell types (6). The expression of Pparg is 248 
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strong in most trophoblast cells, with the exception of P-TGCs, and remains 249 
so for the duration of placentation.  The role of PPARγ/RXRα heterodimers in 250 
placental biology has been extensively investigated and studies implicate 251 
pleiotropic functions in trophoblast development and maintenance (35). RA 252 
synthesized by GlyT is likely to influence several trophoblast cell types in the 253 
developing placenta, predominantly through PPAR and RXR signaling.   254 
 255 
P-TGCs are potentially exposed to both decidual-derived RA (via ALDH1A2) 256 
as well as GlyT-derived RA (via ALDH1A3), and all-trans RA induces 257 
trophoblast differentiation towards a P-TGC fate both in vivo and in vitro 258 
(1,13).  Interestingly, P-TGCs express Cyp26b1 at E8.5, an enzyme that 259 
catabolizes active RA and protect cells from its differentiating effect (36). 260 
Cyp26b1 expression may coincide with terminally differentiated P-TGCs no 261 
longer requiring RA signaling.  Alternatively, one could speculate that 262 
Cyp26b1 expression may act to sensitize P-TGCs to 9-cis-RA signaling; 263 
CYP26A1 and B1 have a specificity for catabolizing all-trans-RA, whereas 264 
CYP26C1, of which we found no expression in trophoblast cells, preferentially 265 
catabolizes 9-cis-RA (37). Cyp26b1 expression by P-TGCs could possibly 266 
exclude all-trans-RA signaling following differentiation while retaining 267 
responsiveness to 9-cis-RA signaling, presumably through RXR/PPARβ/δ. 268 
Such a mechanism could distinguish between different types of RA signaling, 269 
perhaps segregating differentiation signals from those required for cell 270 
behaviours such as migration and endocrine production. 271 
 272 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 12
Cyp26b1 expression was also detected in an unidentified JZ cell type. The 273 
expression of Cyp26b1 in this environment may identify JZ progenitor cells 274 
that would be needed for the ongoing expansion of this layer or for secondary-275 
TGCs, as Cyp26b1 expression would protect these cells from the 276 
differentiating effects of RA.  It has previously been suggested that JZ cells 277 
are able to terminally differentiate into secondary TGC as O2 increases near 278 
vessels (38).  As we observed a loss of Aldh1a3 in GlyT cells closest to spiral 279 
arteries, it is tempting to speculate that this may allow differentiation into SpA-280 
TGCs as spiral arteries expand in the second half of gestation. This notion 281 
may also help to explain the discrepancy observed between GlyT cell 282 
numbers leaving the JZ and arriving in the MD (39), if they are being recruited 283 
to form SpA-TGCs.  284 
 285 
Inhibition of endogenous ALDH1 activity led to a significant decrease in JZ 286 
cell type markers Tpbpa, Prl7b1 and Prl7a2 by citral and a significant 287 
reduction in Tpbpa and Prl7b1 expression by DEAB in TS cell cultures. While 288 
our in vitro TS cell experiments cannot inform us as to the function of GlyT-289 
derived RA later in gestation, they do indicate that differentiating TS cells are 290 
influenced by endogenously produced RA. The decrease in Tpbpa, Prl7b1 291 
and Prl7a2 expression following ALDH1 inhibition highlights a potential 292 
function of EPC ALDH1A3 in regulating differentiation and expansion of the 293 
JZ trophoblast population.  294 
 295 
Expression of Aldh1a3 in mature GlyT cells of the definitive placenta may play 296 
an autocrine role, facilitating proliferation and driving invasion into the 297 
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maternal decidua.  Following E12.5, GlyT increase greatly in number and 298 
begin invading interstitially into the decidua in streams which remain in 299 
contact with one another (39). PPARγ/RXRα heterodimers, both of which are 300 
expressed in GlyT, have been implicated in the invasion of human extravillous 301 
cytotrophoblast, an analogous cell type to murine GlyT (14,40). Aldh1a3 is 302 
also the predominant isoform in breast cancer stem cells and is a robust 303 
predictor of metastatic behaviour (41).  304 
 305 
While the function of GlyT cells remains incompletely understood, Aldh1a3 306 
expression in the early EPC suggests GlyT progenitors may play a role in 307 
regulating the early differentiation of JZ cell types, a notion supported by 308 
inhibition of endogenously produced RA in differentiating TS cell cultures. 309 
Later expression of Aldh1a3 in GlyT suggests a role in GlyT functions such as 310 
migration, or even perhaps in the differentiation into later born SpA-TGCs. It 311 
would be informative to analyze the placentae of Aldh1a3 mutant embryos, 312 
which die shortly after birth due to defects in airway development, to ascertain 313 
whether differentiation of JZ cell types, GlyT invasion or spiral artery 314 
remodeling is adversely affected, and therefore whether there is a placental 315 
contribution to the developmental phenotypes seen in mutant embryos.  316 
 317 
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Figure Legends 1 
Figure 1. Aldh1a3 expression is restricted to cells of the ectoplacental cone 2 
(EPC) and glycogen trophoblast (GlyT) cells of the definitive mouse placenta. 3 
A: Aldh1a3 expression is seen in cells of the maternal decidua above the 4 
uterine lumen (UL) and in trophoblast cells of the EPC at E8.5.  B: Aldh1a3 5 
mRNA is detected in cells of the junctional zone (JZ) at E14.5.  C/D: Serial 6 
sections show analogous expression of Aldh1a3 mRNA and Best’s Carmine 7 
glycogen staining in GlyT cells of the JZ at E12.5, respectively.  Higher 8 
magnification depicted in boxed areas.  E/F: Serial sections show comparable 9 
expression patterns for Aldh1a3 (E) and Prl7b1 (F) at E14.5 in GlyT cells 10 
throughout the JZ.  G/H: Serial sections at E8.5 show expression of Aldh1a3 11 
(G) and Prl7b1 (H) in the ectoplacental cone (EPC).  While these markers can 12 
be seen highlighting the same population of cells, Aldh1a3 (G) also appears 13 
to be solely marking a discrete population in the centre of the EPC (dashed 14 
outline).  Note that Prl7b1 (H) expression, though stronger, appears to also 15 
mark an increased number of peripheral EPC cells.    I/J: Serial sections at 16 
E14.5 of the maternal decidua show glycogen trophoblast cells appear to lose 17 
their expression of Aldh1a3 (I) when situated close to maternal spiral arteries 18 
(MSAs), indicated by arrows.  Prl7b1 (J) expression on the other hand is not 19 
lost in these cells.  In addition, Prl7b1 is seen to mark spiral artery-associated 20 
trophoblast giant cells of the MSAs, indicated by red asterisks.   Ch, chorion; 21 
Dec, decidua; Lab, labyrinth; SpT, spongiotrophoblast cells.  Scale Bars = 22 
1mm (red), 100µm (black). 23 
 24 
 25 
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 2 
Figure 2. Expression of retinoic acid metabolising enzymes Aldh1a2 and 26 
Cyp26b1 in the mouse placenta. A: Expression of Aldh1a2 can be seen in the 27 
mesometrial pole of the uterus and in the embryo (E) proper at E8.5. B: At 28 
E14.5 Aldh1a2 is restricted to the maternal decidua (Dec). C/D: At E8.5 29 
Cyp26b1 expression in seen in the parietal-TGC layer (C) and anti-30 
mesometrial pole (D) of the uterus. E: At E14.5 Cyp26b1 can be seen 31 
expressed throughout the junctional zone (JZ) in an unidentified cell type. 32 
Lab, labyrinth.  Scale bars = 1mm (red), 100µm (black). 33 
 34 
Figure 3.  Overview of In situ hybridisation (ISH) results for mRNA expression 35 
of Rar (a/b/g), Rxr (a/b/g) and Ppar (d/g) in coronal placental sections at E8.5 36 
(A) and E14.5 (B).  (+) Reported in this study; for details refer to supplemental 37 
file 1; ISH images provided in supplemental figures (Fig S4 to Fig S11).  [1] 38 
Sapin et al, 1997 (42); [2] Nadra et al, 2006 (43); [3] Barak et al, 1999 (7). 39 
 40 
Figure 4. Classical retinoic acid signalling is seen in the labyrinth (Lab) and 41 
junctional zone (JZ) of the definitive mouse placenta.  A: At E8.5 coronal 42 
cryosections through the implantation site are negative for LacZ expression in 43 
the developing chorion, ectoplacental cone (EPC) or parietal-TGC layer.  44 
LacZ positive cells are evident in the embryo (E) proper.  B/C: LacZ positive 45 
cells can be seen in unknown cell types of the JZ (B) and Lab (C) at E14.5.  46 
Scale bars = 1mm (red), 200µm (black).  47 
 48 
Figure 5. ALDH inhibitors (Citral/DEAB) downregulate the expression of 49 
junctional zone cell type markers in differentiated (Day 6) trophoblast stem 50 
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(TS) cell cultures.  A-C: Labyrinth cell type specific markers (Prl3d1, Syna, 51 
Ctsq) show no significant change in expression following the loss of 52 
endogenous ALDH1 activity.  D-F: Junctional Zone cell type markers (Tpbpa, 53 
Prl7a2, Prl7b1) show significantly less expression in differentiated TS cells 54 
following treatment with Citral.  D: Tpbpa and Prl7b1 were also significantly 55 
decreased following treatment with DEAB (* p<0.05, ** p<0.005).   56 
 57 
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Supplemental Figure Legends 
Figure S1:  In Situ Hybridization showing Aldh1a3 spatial expression from E8.5 to E18.5 
in coronal placental sections.  A: Implantation site at E8.5 shows Aldh1a3 expression in 
the expanding ectoplacental cone (EPC).  Expression can also be seen throughout the 
maternal decidua above the uterine lumen (UL), E: Embryo.  B: E10.5 placental section 
shows expression of Aldh1a3 in the expanding junctional zone (JZ) adjacent to the 
developing labyrinth (Lab).  Note expression of Aldh1a3 in the decidua is lost.  C: E12.5 
placenta shows expression of Aldh1a3 in glycogen trophoblast (GlyT) cells of the JZ.  D: 
E14.5 placenta sees Aldh1a3 mRNA expressed in GlyT cells within the JZ and GlyT cells 
migrating into the decidua in close proximity to the maternal spiral arteries.  Aldh1a3 
transcripts can also be seen in GlyT cells at E16.5 (E) and E18.5 (F) within the JZ and 
maternal decidua. Higher magnifications shown in boxed areas.   
Figure S2: In Situ Hybridization showing spatial expression of Prl7b1 (A-F) compared 
to Aldh1a3 (A1-F1) in transverse serial sections of E8.5 ectoplacental cone (EPC).  A: 
The uterine lumen (UL) can be seen central to each section.  There are no Prl7b1 (A) 
positive cells.   Aldh1a3 (A1) expression is evident in the maternal decidua.  B: Cells of 
the EPC begin to emerge and are positive for both Prl7b1 (B) and Aldh1a3 (B1).  
Aldh1a3 positive maternal stromal cells are also present in the periphery (B1).  C/D: 
Central EPC cells are positive for both Aldh1a3 (C1/D1) and Prl7b1 (C/D).  E/F: 
Expression of Prl7b1 (E/F) mRNA is lost.  A small number of Aldh1a3 (E1/F1) positive 
cells are still detected as sections approach the chorion (Ch) of the developing placenta.  
Cells expressing Aldh1a3 can be seen for a further 140 microns beyond the loss of 
expression of Prl7b1. Cartoon inset shows the orientation of UL, EPC and developing Ch 
at E8.5.  Dashed lines represent the level of Prl7b1 (black) and Aldh1a3 (blue) sections. 
Figure S3: In Situ Hybridization showing expression of Aldh1a3 (A/C) matches that of 
Pcdh12 (B/D) in serial sections of the ectoplacental cone at E8.5 (A/B), and in glycogen 
trophoblast cells within the junctional zone and maternal decidua at E14.5 (C/D).  
Figure S4:  In Situ Hybridization depicting lack of expression of various retinoic acid 
metabolising enzymes in mouse placental tissue.  A/B: Aldh1a1 is not expressed in 
placental tissue at E8.5 or E14.5.  C: Expression of Aldh1a1 can be seen in the lens of the 
adult mouse eye, used as control tissue.  D: Cyp26a1 expression is absent from E8.5 
ectoplacental cone and chorion, however can be seen in uterine epithelium shown in 
higher magnification in boxed area.  E: Cyp26a1 is also absent from E14.5 placental 
tissue, however expression is evident in uterine epithelial tissue shown in higher 
magnification in boxed area.  F/G: Cyp26c1 is also absent from E8.5 and E14.5 placental 
sections.  Expression is evident in the developing embryo at E8.5 (F).  
Figure S5: A/B: Expression of RARα is absent from the ectoplacental cone (EPC) and 
majority of the chorion at E8.5 (A). RARα mRNA is weakly evident in the allantois (A) 
and in the base of the chorion (B).  C: Expression of RARα is seen throughout the 
mesometrial pole of the uterus and in cells lining uterine glands at E8.5.  D: Expression 
of RARα in the labyrinth at E14.5 is detected weakly throughout with stronger 
expression associated with fetal vasculature. 
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Figure S6: A/B: Expression of RARβ mRNA is not evident in placental tissue at E8.5 or 
E14.5. 
Figure S7: A/B: Expression of RARγ is absent from the ectoplacental cone (EPC) and 
majority of the chorion at E8.5.  RARγ mRNA is weakly evident in the expanding 
allantois, where it joins the base of the chorion and at branching points at this time.  C: 
At E14.5 expression of RARγ is seen diffusely throughout the maternal decidua.  D: 
Expression of RARγ in the labyrinth at E14.5 is most strongly associated with the fetal 
vasculature. 
Figure S8: A/B: In situ hybridisation analysis of RXRα mRNA shows expression in the 
ectoplacental cone (EPC), chorion (Ch) and parietal trophoblast giant cell (asterisk) 
layer at E8.5.  C/D: E14.5 expression of RXRα mRNA.  D: Higher magnification shows 
transcripts present in the labyrinth (beneath dotted line) and in clusters of glycogen 
trophoblast cells (arrows) throughout the junctional zone and maternal decidua.  RXRα 
is not seen in spongiotrophoblast cells of the junctional zone.  
Figure S9: A: Expression of RXRβ mRNA at E8.5 can be seen in the ectoplacental cone 
(EPC) and chorion (Ch).  B/C: Sections at E14.5 show RXRβ mRNA present in the 
labyrinth (beneath dotted line) and in clusters of glycogen trophoblast cells (arrows) of 
the junctional zone and maternal decidua, seen more clearly in higher magnification (C).  
Some weak expression may also be present in spongiotrophoblast cells.   
Figure S10: A/B: In situ hybridisation analysis of RXRγ mRNA shows expression in the 
chorion (Ch) and parietal trophoblast giant cell (arrows) layer at E8.5.  Strong 
expression is also evident in cells of the ante-mesometrial pole of the uterus (B).  C/D: 
E14.5 expression of RXRγ mRNA.  D: Higher magnification shows weak expression of 
transcripts in the labyrinth (beneath dotted line) and in clusters of glycogen trophoblast 
cells (asterisk) throughout the junctional zone and maternal decidua.  RXRγ is not seen 
in spongiotrophoblast cells of the junctional zone.  
Figure S11: A: In situ hybridisation analysis of PPARδ/β reveals expression throughout 
the ectoplacental cone and in the top layer of cells of the chorion at E8.5 (seen in higher 
magnification in boxed area).  B: PPARδ/β mRNA is seen in parietal trophoblast giant 
cells surrounding the implantation site at E8.5.  C: Weak expression of PPARδ/β can be 
seen throughout the junctional zone and labyrinth in E12.5 placental sections.  
Expression of PPARδ/β mRNA in glycogen trophoblast cells (asterisk) of the junctional 
zone at E12.5 can be seen in higher magnification (boxed area).     
Figure S12: A: In situ hybridisation analysis of PPARγ shows expression throughout the 
ectoplacental cone and in the chorion at E8.5. PPARγ mRNA is absent from the parietal 
trophoblast giant cell layer (asterisk) at this time point.  B-D: PPARγ mRNA expression 
in E14.5 coronal placental sections.  C: Expression of PPARγ can be seen throughout the 
junctional zone in glycogen trophoblast cells and spongiotrophoblast cells at E14.5.  D: 
Expression of PPARγ mRNA in cells of the labyrinth at E14.5.     
Figure S13:  Additional qRT-PCR results for expression levels of various trophoblast cell 
marker genes in ALDH1 inhibitor treated trophoblast stem (TS) cells normalised to 
Hprt1 and Rpl13a house keeper genes.  As with Rn18s, downregulation of expression of 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
junctional zone cell type markers in differentiated (Day 6) TS cell cultures was observed.  
A-C: Labyrinth cell type specific markers (Prl3d1 and Ctsq) show no significant change in 
expression following the loss of endogenous ALDH1 activity.  Syna shows a decrease in 
expression in citral treated cells when normalised to Hrpt1 expression.  D-F: Junctional 
Zone cell type markers (Tpbpa, Prl7b1, Prl7a2) show significantly less expression in 
differentiated TS cells following treatment with Citral.  D/E: Tpbpa and Prl7b1 were also 
significantly decreased following treatment with DEAB (* p<0.05, ** p<0.005, 
***p<0.001). 
Figure S14: Quantitative RT-PCR results of endogenous Aldh1a3 expression in 
trophoblast stem cell cultures over 6 days of differentiation. 
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Highlights 
 
• Aldh1a3 is expressed by glycogen trophoblast cells of the murine 
placenta 
 
• Glycogen trophoblast cells may be a local source of placental retinoic 
acid 
 
• All trophoblast subtypes of the mouse placenta express some 
complement of RA receptors 
 
• Inhibition of endogenous ALDH1 enzymes in TS cell cultures alters 
differentiation  
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Detailed description of ISH analysis of RA metabolizing enzymes and receptors 
during murine placental Development. 
At E8.5, Rara transcripts were expressed within the mesometrial pole and glandular 
epithelium of the uterus (Fig 3, Fig S4C), plus weak and diffuse expression of Rarg in the 
mesometrial and anti-mesometrial poles of the uterus, consistent with previously reported 
findings (1) (data not shown).  Rara and Rarg were also found to be weakly expressed in the 
allantois with Rara present in the base of the chorion (Fig S4A/B, S6A/B).  No expression of 
Rarb was observed (Fig S5A).  Expression of all Rxr isoforms was seen in both poles of the 
uterus (data not shown), the EPC and developing chorion (Fig S7A/S8A/S9A) plus the P-
TGC layer (Fig S7B/S8A/S9B) surrounding the implantation site.  Interestingly, chorionic 
expression of Ppard was restricted to the top layer of the chorion (Fig S10A), and was also 
seen in the EPC and P-TGC layer surrounding the conceptus (Fig S10B).  In contrast, Pparg 
was excluded from the P-TGC layer but was evident within the EPC and chorion (Fig S11A).  
No uterine expression of either Ppar isoform was observed. 
At E14.5 Rara and Rarg were expressed in cells associated with the fetal derived 
vasculature within the labyrinth (Fig S4D/S6D), while Rarg also exhibited diffuse expression 
throughout the maternal decidua (Fig S4C).  No expression of Rarb was detected in the 
definitive placenta (Fig S5B). Expression of Rxra was observed weakly throughout the 
maternal decidua (MD) (data not shown) and more definitively in GlyT and labyrinth cell 
types (Fig S7D).  Similarly, Rxrg was expressed in GlyT of the JZ and cells of the labyrinth 
(Fig S9D). Rxrb transcripts were detected in the labyrinth, GlyT and possibly a small subset 
of SpT cells of the JZ (Fig S8C).  The Ppard isoform was detected weakly at E12.5 in JZ cell 
types and additionally in the expanding labyrinth (Fig S10C).  Of note, Ppard expression 
appeared to decrease following a peak at E10.5 and was undetected by E16.5 (data not 
shown), consistent with previously reported relative mRNA expression findings (2).  Pparg 
was observed in GlyT and SpT cells of the JZ and extensively throughout the labyrinth (Fig 
S11B-D). 
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β-galatosidase activity, while robust in the developing embryo at E8.5, was not seen in the 
EPC or chorion of the developing placenta. This is consistent with receptor mRNA 
expression, as we found no evidence of overlapping Rar/Rxr expression in the developing 
EPC at E8.5. At E14.5, while sparse, lacZ expression was observed in areas that had some 
expression of both Rar and Rxr transcripts. 
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Table1: Primer pair sequences used in the production of In Situ Hybridisation probes. 
cDNA Direction Sequence (5’-3’) Product 
(bp) 
Aldh1a1* Forward CCAGCAATGTCTTCGCCT 521 
 Reverse TTTGGCCACACACTCCAA  
Aldh1a2* Forward GTATATGGGAGCCCTCATCAAG 921 
 Reverse CTTCTTAGGAGTTCTTCTGGGG  
Aldh1a3 Forward AATTAACCCTCACTAAAGGGATAAGCCCGATGTGGACAAG 1100 
 Reverse TAATACGACTCACTATAGGGTTGCCTCCTAGCTCCAGTGT  
Cyp26a1* Forward TGACCCGCAATCTCTTCTCT 815 
 Reverse GTGGGGCTTGTCTTCATTGT  
Cyp26b1* Forward TCTCCACTGCCACCTAGCTT 807 
 Reverse TACACCTGGCAGAGATGCAG  
Cyp26c1* Forward TCCTCTCTGGAGCAATTCGT 750 
 Reverse AACCGTCCAGTTCAAAGGTG  
PPARα* Forward GCAGCTCGTACAGGTCATCA 853 
 Reverse AACTACCTGCTCAGGGCTCA  
PPARβ/δ* Forward CAGAATTCCTCCCCTTCCTC 915 
 Reverse GGAGACTTCGCAAGAACTCG  
PPARγ* Forward CCTTGCTGTGGGGATGTC 941 
 Reverse GGGTGGGACTTTCCTGCT  
RARα Forward AATTAACCCTCACTAAAGGGAGGGGGACCCAGAAGACTAA 863 
 Reverse TAATACGACTCACTATAGGGCAATGTCCAGGGAGACTCGT  
RARβ Forward AATTAACCCTCACTAAAGGGGACCTTGAGGAACCAACAAAAG 760 
 Reverse TAATACGACTCACTATAGGGACAACCTCGGTGTCTTGGTTAT  
RARγ Forward AATTAACCCTCACTAAAGGGTGAGGACGAAGCTCCAGG 624 
 Reverse TAATACGACTCACTATAGGGTTCTCCCTTCCCCCTCAG  
RXRα Forward AATTAACCCTCACTAAAGGGGGAATGAGAACGAGGTGGAG 491 
 Reverse TAATACGACTCACTATAGGGAGGGTTGAACAGGACAATGG  
RXRβ                  Forward AATTAACCCTCACTAAAGGGCTGCAAGGGTTTCTTCAAGC 791 
 Reverse TAATACGACTCACTATAGGGCCTGCTGCTCAGGGTACTTC  
RXRγ                  Forward AATTAACCCTCACTAAAGGGGCCACTCTTGTTAGCCCAAG 490 
 Reverse TAATACGACTCACTATAGGGAAGGGCTTGATGTCCTCAGA  
Probe templates were generated by PCR with included RNA polymerase binding sites (T3 – Forward 
and T7 – Reverse as indicated; RNA polymerase binding sites are represented in bold).  * Some 
probe templates were cloned into pGEM-Teasy and therefore lacked T3 or T7 sequences in the 
primers.  The forward and reverse probes for Prl7b1 have been previously described (1). 
 
 
 
 
1. Simmons DG, Rawn SM, Davies A, Hughes M, Cross JC. Spatial and 
temporal expression of the 23 murine Prolactin/Placental Lactogen-related 
genes is not associated with their position in the locus. BMC Genomics 
2008;9(1):352. 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 
 
 
 
 
 
Table 2: Primer pair sequences for individual genes used in qRT-PCR 
Gene Forward Reverse 
Rn18s GTAACCCGTTGAACCCCATT CCATCGAATCGGTAGTAGCG 
Aldh1a3 AGGCTGTATTAAGACCTTCAG GGAAGTTCCATGGTGTAATG 
Prl3d1/PL1 CTGCTGACATTAAGGGCA AACAAAGACCATGTGGGC 
Syna ATGGAGAAACCCCTTACGCT TAGGGGTCTTTGTGTCCCTG 
Ctsq TTCATTGGCCCAATACCCTA GAAAGCTCCCAGAATTCACA 
Tpbpa AAGTTAGGCAACGAGCGAAA AGTGCAGGATCCCACTTGTC 
Prl7b1 GGGAGGACGTGGTCTCTGTA TTTGGTGATTTGAGTGGCAA 
Prl7a2 GGGAGAATGTGGCCTCTGTA TTGAGCTTCGTCCAGGTTTT 
Rn18s: 18s Ribosomal RNA, Aldh1a3: Aldehyde dehydrogenase 1 family, member a3, Prl3d1: 
Prolactin family 3, subfamily d, member 1, PL1: Placental lactogen 1, Syna: syncytin a, Ctsq: 
Cathepsin Q, Tpbpa: Trophoblast specific protein a, Prl7b1: Prolactin family 7, subfamily b, member 
1, Prl7a2: Prolactin family 7, subfamily a, member 2. 
 
 
 
 
 
 
 
 
 
 
